BPMSS – Lonza's Biopharmaceutical Small Scale Plant Started cGMP Manufacturing in September 2004

BPMSS – Lonza's Biopharmaceutical Small Scale Plant Started cGMP Manufacturing in September 2004

In September 2004 Lonza (Visp, Switzerland) started operations in a new state of the art facility for cGMP manufacture of injectable grade microbially derived biopharmaceuticals. Both intracellular and secreted products can be processed in the new production line, which delivers bulk drug...

Full description

Bibliographic Details
Main Authors: Frans W.J.M.M. Hoeks, Diego R. Schmidhalter, Rainer Gloeckler, Christoph Herwig, Karen Theriault, Sven Frie, Wouter van den Broek, Frank Laukel
Format: Article
Language:deu
Published: Swiss Chemical Society 2005-01-01
Series:CHIMIA
Subjects:
Cgmp
Chromatography
Custom manufacturing
Ex-proof
Intracellular and extracellular
Lonza
Online Access:https://chimia.ch/chimia/article/view/3940

Internet

https://chimia.ch/chimia/article/view/3940

Similar Items